The Consensus Guidelines Library is IMA’s central repository for global standards, evidence-based guidelines, regulatory frameworks and strategic research roadmaps.
It supports worldwide alignment in terminology, safety, interoperability and real-world implementation.
(1) International Consensus Guidelines Statements
This section includes major Consensus Guidelines documents developed by IMA and global partners:
- Expert consensus on the diagnosis and treatment of malignant peritoneal mesothelioma
- Expert Consensus on the Diagnosis and Treatment of Malignant Mesothelioma of the Tunica Vaginalis Testis
- International guidelines on the diagnosis and treatment of NUT carcinoma
- Expert Consensus on the Diagnosis and Treatment of Malignant Pericardial Mesothelioma
- Expert consensus on the diagnosis and treatment of non-small cell lung cancer with MET alteration
- Expert consensus on cancer treatment-related lung injury
- ECLUNG Consensus/Guidelines Development Principles and Methods (2024 Edition)
- Expert consensus on the diagnosis and treatment of solid tumors with BRAF mutations
- Clinical best practices in interdisciplinary management of human epidermal growth factor receptor 2 antibody-drug conjugates-induced interstitial lung disease/pneumonitis: An expert consensus in China
- Expert Consensus on the Diagnosis and Treatment of FGFR Gene-Altered Solid Tumors
- Expert consensus on the diagnosis and treatment of NTRK gene fusion solid tumors in China
- Expert consensus on the diagnosis and treatment of RET gene fusion non‐small cell lung cancer in China
- Chinese expert consensus on the diagnosis and treatment of malignant pleural mesothelioma
- Chinese expert consensus on the diagnosis and treatment of thymic epithelial tumors
- Chinese expert consensus on the diagnosis and treatment of HER2 ‐altered non–small cell lung cancer
- Chinese expert consensus on the multidisciplinary management of pneumonitis associated with immune checkpoint inhibitor
- Expert consensus on the diagnosis and treatment of NTRK gene fusion solid tumors in China
